Plasma and urinary levels of triamterene and certain metabolites after oral administration to man. 1979

U Gundert-Remy, and D von Kenne, and E Weber, and H E Geissler, and B Grebian, and E Mutschler

The plasma and urinary levels of triamterene and two metabolites were measured using a specific method of analysis. Urinary excretion was completed after 48 h, which permitted a rough estimate of its half-life as longer than two hours. The areas under the curve were 672.5 +/- 160.3 and 1.311.3 +/- 399.1 micrograms/ml X h after the triamterene 150 mg and 300 mg p.o., respectively and correspondingly 4.2 +/- 1.4% and 3.7 +/- 0.6% of the dose were excreted as unchanged drug. The principal metabolite of triamterene found was the sulfate conjugate. The area under the curve of this metabolite amounted to 6.672 +/- 2.120 and 11.941 +/- 5.005 micrograms/ml X h after the of 150 mg and 300 mg triamterene doses, respectively. The urinary excretion of the metabolite varied between 25.0 +/- 4.0% and 17.5 +/- 3.5% of the dose after either dose. In healthy subjects an effect on sodium excretion was observed after a dose of 150 mg, whereas the potassium-retaining effect was observed only after the dose of 300 mg.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006900 Hydroxylation Placing of a hydroxyl group on a compound in a position where one did not exist before. (Stedman, 26th ed) Hydroxylations
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014223 Triamterene A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS. Dyrenium,Dytac,Urocaudal

Related Publications

U Gundert-Remy, and D von Kenne, and E Weber, and H E Geissler, and B Grebian, and E Mutschler
October 1977, International journal of clinical pharmacology and biopharmacy,
U Gundert-Remy, and D von Kenne, and E Weber, and H E Geissler, and B Grebian, and E Mutschler
January 1954, Acta pharmacologica et toxicologica,
U Gundert-Remy, and D von Kenne, and E Weber, and H E Geissler, and B Grebian, and E Mutschler
January 1999, The Journal of pharmacy and pharmacology,
U Gundert-Remy, and D von Kenne, and E Weber, and H E Geissler, and B Grebian, and E Mutschler
May 1994, Xenobiotica; the fate of foreign compounds in biological systems,
U Gundert-Remy, and D von Kenne, and E Weber, and H E Geissler, and B Grebian, and E Mutschler
February 1981, European journal of clinical pharmacology,
U Gundert-Remy, and D von Kenne, and E Weber, and H E Geissler, and B Grebian, and E Mutschler
January 1972, Clinical pharmacology and therapeutics,
U Gundert-Remy, and D von Kenne, and E Weber, and H E Geissler, and B Grebian, and E Mutschler
July 1972, Journal of pharmaceutical sciences,
U Gundert-Remy, and D von Kenne, and E Weber, and H E Geissler, and B Grebian, and E Mutschler
March 1992, Xenobiotica; the fate of foreign compounds in biological systems,
U Gundert-Remy, and D von Kenne, and E Weber, and H E Geissler, and B Grebian, and E Mutschler
April 1974, Journal of pharmacokinetics and biopharmaceutics,
U Gundert-Remy, and D von Kenne, and E Weber, and H E Geissler, and B Grebian, and E Mutschler
January 1979, Therapie,
Copied contents to your clipboard!